RAPT Therapeutics RAPT

$ 0.83 0.0%

Quarterly report 2024-Q3
added 11-12-2024

RAPT Therapeutics Income Statement 2011-2024 | RAPT

Annual Income Statement RAPT Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	358 M	640 M	1.01 B	487 M	194 M	-	-	-	-	-	-	-	-
Shares	38.3 M	32.5 M	27.4 M	24.4 M	4.35 M	-	-	-	-	-	-	-	-
Historical Prices	9.35	19.7	36.7	19.8	27.6	-	-	-	-	-	-	-	-
Net Income	-117 M	-83.8 M	-69.2 M	-52.9 M	-43 M	-36.1 M	-29.1 M	-	-	-	-	-	-
Revenue	-	1.53 M	3.81 M	5.04 M	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	5.04 M	-	-	-	-	-	-	-	-	-
Operating Income	-127 M	-85.8 M	-69.2 M	-53.2 M	-43.6 M	-36.9 M	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-126 M	-84.7 M	-68.2 M	-52.7 M	-42.3 M	-35.7 M	-27.9 M	-	-	-	-	-	-
Operating Expenses	127 M	87.3 M	73 M	58.3 M	43.6 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	26.1 M	20.2 M	16 M	12.8 M	8.72 M	5.18 M	3.71 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement RAPT Therapeutics

	2024-Q3	2024-Q2	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	38.9 M	38.9 M	38.4 M	38.3 M	38.3 M	-	33.7 M	31.1 M	29.6 M	29.6 M	29.5 M	25.6 M	24.8 M	24.8 M	24.4 M	24.3 M	23.3 M	21.8 M	803 K	719 K	692 K	878 K	647 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-18.4 M	-27.7 M	-31.4 M	-25.3 M	-29.3 M	-	-21.2 M	-19.2 M	-20.5 M	-	-18.7 M	-16.1 M	-16.5 M	-	-14.6 M	-12.4 M	-13.1 M	-	-9.97 M	-10.6 M	-9.19 M	-	-10.3 M	-8.2 M	-8.23 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	1.53 M	886 K	641 K	-	966 K	869 K	1.22 M	-	1.53 M	1.28 M	935 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-19.8 M	-29.3 M	-33.9 M	-28.4 M	-31.6 M	-	-21.7 M	-18.9 M	-20.8 M	-	-18.5 M	-16.1 M	-16.6 M	-	-14.6 M	-12.5 M	-13 M	-	-10.3 M	-11 M	-9.54 M	-	-10.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-19.5 M	-29 M	-33.6 M	-28.1 M	-31.3 M	-	-21.4 M	-18.7 M	-20.5 M	-	-18.3 M	-15.9 M	-16.3 M	-	-14.3 M	-12.1 M	-12.8 M	-	-10 M	-10.6 M	-9.21 M	-	-10.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	19.8 M	29.3 M	33.9 M	28.4 M	31.6 M	-	21.7 M	19.8 M	21.4 M	-	19.5 M	17 M	17.8 M	-	16.1 M	13.8 M	14 M	-	10.3 M	11 M	9.54 M	-	10.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	6.45 M	6.69 M	6.9 M	6.72 M	5.99 M	-	5.08 M	5.44 M	4.75 M	-	3.77 M	3.76 M	4.01 M	-	3.2 M	2.8 M	3.29 M	-	1.73 M	2.69 M	1.67 M	-	1.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency